What is NDC 70512-814?

70512-814 is the product NDC for Coxanto (oxaprozin), Oxaprozin 300 mg/1 capsule, listed with the FDA by SOLA Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

SOLA Pharmaceuticals, LLC, NDC labeler code 70512. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Coxanto?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Coxanto NDC 70512-814 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70512-814Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70512-0814Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70512-814-60	7051208146070512081460	60 CAPSULE in 1 BOTTLE (70512-814-60)Marketed from Nov 3, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Coxanto
Generic name (nonproprietary): oxaprozin
Active ingredients: Oxaprozin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: SOLA Pharmaceuticals, LLCNDC labeler code 70512
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 217927
Marketing start: Nov 3, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 70512-814_419ad65e-5326-0755-e063-6394a90a7b2fSPL ID 419ad65e-5326-0755-e063-6394a90a7b2fSPL set ID 918127f0-9f2a-4edf-a2f7-07c01aa52bb5RxCUI 2668162, 2668168UNII MHJ80W9LRBUPC 0370512814601
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470512081460 followed by a unit qualifier and the quantity

Package 70512-0814-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 20, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

COXANTO is indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis COXANTO is a non-steroidal anti-inflammatory drug indicated for: Relief of signs and symptoms of Osteoarthritis (OA) ( 1 ) Relief of signs and symptoms of Rheumatoid Arthritis (RA) ( 1 ) Relief of signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70512-814

What is NDC 70512-814?: 70512-814 is the product NDC for Coxanto (oxaprozin), Oxaprozin 300 mg/1 capsule, listed with the FDA by SOLA Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Coxanto (Oxaprozin).
What is the active ingredient?: Oxaprozin.
Who is the labeler?: SOLA Pharmaceuticals, LLC, NDC labeler code 70512. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Coxanto?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 217927

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 217927
Product	Strength	Form · route	Labeler	Product NDC
Oxaprozin	Oxaprozin 300 mg/1	CapsuleOral	SOLA Pharmaceuticals, LLC	70512-787

Coxanto (Oxaprozin) NDC 70512-814